Bellevue Life Sciences Acquisition Corp.
(NASDAQ) BLAC
Bellevue Life Sciences Acquisition Corp. Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$2.91M
Net Income (TTM)
$186.00
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
BLAC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bellevue Life Sciences Acquisition Corp.
Industry
Capital Markets
Sector
FinancialsEmployees
4
CEO
Andreas Niethammer, MD, PhD
Website
www.osr-holdings.comHeadquarters
Bellevue, WA 98004, US
BLAC Financials
Key Financial Metrics (TTM)
Gross Margin
20%
Operating Margin
-6%
Net Income Margin
-8%
Return on Equity
-28%
Return on Capital
-12%
Return on Assets
-13%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$592.90K
Operating Income
$18.34M
EBITDA
$18.34M
Operating Cash Flow
$0.00
Capital Expenditure
$0.00
Free Cash Flow
$0.00
Cash & ST Invst.
$1.70M
Total Debt
$0.00
Bellevue Life Sciences Acquisition Corp. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$381.27K
N/A
Gross Profit
$129.70K
N/A
Gross Margin
34.02%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$19.81M
+1079.7%
EBITDA
$10.19M
-375.2%
Quarterly Fundamentals
Net Cash
$1.70M
+200.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-13.00%
N/A
Return on Invested Capital
-11.90%
N/A
Free Cash Flow
$3.26M
+747.8%
Operating Cash Flow
$3.26M
+747.8%